ケンタッキー州における膵臓がんの臨床試験
ケンタッキー州内の拠点で、膵臓がんに関する13件の研究が参加者を募集しています。
ケンタッキー州内の都市
公式研究テキスト（英語）
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
- University of Kentucky/Markey Cancer Center, Lexington
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT05372614A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- University of Kentucky Research Foundation, Lexington
- University of Kentucky Healthcare - Markey Cancer Center, Lexington
- University of Kentucky Medical Center, Lexington
- 他1件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06989437A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
- Saint Elizabeth Medical Center, Inc. DBA St. Elizabeth Health Care, Edgewood
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07409272Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
- University of Kentucky/Markey Cancer Center, Lexington
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/25更新 · NCT06958328EXoPERT EMERALD Clinical Study
- Lexington VA Healthcare System, Lexington
- KCTL, Louisville
被験者募集中観察研究健康なボランティア歓迎
45歳以上 · 全性別 · 2026/07/01更新 · NCT07186296Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Norton Cancer Institute /ID# 248903, Louisville
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/23更新 · NCT05005403Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
- Flaget Memorial Hospital, Bardstown
- Commonwealth Cancer Center-Corbin, Corbin
- Saint Joseph Hospital, Lexington
- 他4件
被験者募集中第3相
18歳以上 · 全性別 · 2026/05/22更新 · NCT06998940Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
- University of Kentucky/Markey Cancer Center, Lexington
被験者募集中第3相
18歳以上 · 全性別 · 2026/03/31更新 · NCT06807437A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- Ohio State University-Telemedicine, Lexington
被験者募集中第2相
18歳以上 · 全性別 · 2026/02/17更新 · NCT06906562cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Baptist Corbin, Corbin
- Baptist Hardin, Elizabethtown
- Baptist Lexington, Lexington
被験者募集中観察研究健康なボランティア歓迎
40歳以上 · 全性別 · 2026/01/20更新 · NCT05366881GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
- University of Kentucky, Lexington
被験者募集中
18歳以上 · 全性別 · 2025/12/16更新 · NCT05391126Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma
- University of Louisville, Louisville
被験者募集中第1相
18歳以上 · 全性別 · 2025/10/29更新 · NCT03484299American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
- University of Louisville, Louisville
被験者募集中観察研究
18歳以上 · 全性別 · 2025/02/25更新 · NCT02674100ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。